Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00294034 · ClinicalTrials.gov registry record

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

A clinical trial of Bradycardia and Pacemaker, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
950
Enrollment target
20
Study locations

NCT00294034: Completed study of Bradycardia and Pacemaker, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

NCT00294034 is a study of Bradycardia and Pacemaker that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 950 participants, below the 4,380-participant average among 29 other Bradycardia trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00294034, a study of Bradycardia and Pacemaker, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
950 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to collect data from pacemakers and determine how this information is used by physicians to care for their patients with pacemakers.

Conditions Studied

Bradycardia Pacemaker

Interventions

  • DEVICE Pacemaker

Study Locations (20)

Ohio

  • - Barberton
  • - Cincinnati
  • - Marion
  • - Massillon
  • - Middletown

Florida

  • - Fort Lauderdale
  • - Largo
  • - Ormond Beach
  • - St. Petersburg

Arkansas

  • - Hot Springs
  • - Little Rock
  • - North Little Rock

Kentucky

  • - Edgewood
  • - Louisville

New York

  • - Bay Shore
  • - Syracuse

Illinois

  • - Chicago

Massachusetts

  • - Hyannis

Michigan

  • - Lansing

Trial Details

FieldValue
Enrollment Target 950 participants
Start Date 2002-10
Est. Completion 2006-05
Medtronic Cardiac Rhythm and Heart Failure

115 total trials

What the finished NCT00294034 record still lists

NCT00294034 is an observational study that tracks outcomes without assigning an intervention. The registered 950 participants enrollment target is mid-sized for trials with a published cap, below the 4,380-participant average among 29 other Bradycardia trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Pacemaker is the first listed.

NCT00294034 names 20 study sites across 9 states, led by Ohio, Florida, Arkansas.

Frequently Asked Questions

What is clinical trial NCT00294034 about?

NCT00294034 is a clinical study titled "VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies". The purpose of this study is to collect data from pacemakers and determine how this information is used by physicians to care for their patients with pacemakers.

What is the current status of trial NCT00294034?

This trial is currently completed. The enrollment target is 950 participants. The study started on 2002-10. Estimated completion is 2006-05.

What conditions does trial NCT00294034 study?

This clinical trial studies the following conditions: Bradycardia, Pacemaker.

What interventions are being tested in trial NCT00294034?

The interventions under investigation include: Pacemaker (DEVICE).

Who is sponsoring clinical trial NCT00294034?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00294034 being conducted?

This trial has 20 study locations across Arkansas, Florida, Illinois, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00294034's enrollment target sits among peer trials

950 13th of 29 higher than 16 of 29 other Bradycardia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bradycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03784924 · 950 participants

    EDRN Prostate MRI Biomarker Study

  • NCT04180930 · 950 participants

    An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

  • NCT04895709 · 949 participants · Phase 1

    A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

  • NCT04375033 · 952 participants · Phase 4

    A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00294034, the US trial registry maintained by the National Library of Medicine. NCT00294034 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.